Full List Of Stories
Biogen dives after canning Alzheimer's drug trials
Biogen shares plummeted on Thursday after the company confirmed that it will cease clinical trials for aducanumab, the experimental Alzheimer’s disease treatment it developed alongside its Nikkei 225-listed Japanese partner Eisai.
FTSE 250 movers: Renishaw rocked, Hunting gushes higher
London's FTSE 250 was 0. 42% lower at 19,306. 99 in afternoon trading on Thursday, as Renishaw led the index lower.
SafeStyle profits slip amid 'disruption' from new competitor
Safestyle on Thursday reported that it swung to a loss in 2018 as the business incurred litigation costs and "an unprecedented period of disruption and change" resulted in a drop in revenue.
Sopheon sales visibility softens
Sopheon's shares slipped on Thursday despite outperforming in 2018 after the software developer reported that revenue growth was likely to slow in the current year.
Game Digital scores profit rise despite revenue drop
Computer games retailer Game Digital reported that cost-cutting had led to an increase in interim profits, despite a drop in revenue.
Wynnstay warns on profits as farmers eye Brexit, weather
Wynnstay Group's shares plummeted on Thursday after the agricultural products supplier said it was trading behind seasonal norms amid Brexit uncertainty and warned that its interim results will fall "substantially" compared to last year.